FDA Eases Regulations on Female Condoms

The FDA reclassified single-use female condoms from Class III to Class II, lowering the regulatory burden for makers of the contraceptive devices.

FDA Eases Regulations on Female Condoms
FDA Eases Regulations on Female Condoms

A recent article from the Regulatory Affairs Professionals Society says it’ll be easier for makers of female condoms to bring their product to market. Last week, the FDA issued a final order that reclassified single-use female condoms from Class III to Class II. The order will take effect at the end of October after years of women’s health advocates campaigning for easier access.

Only one female condom is currently sold in the US, and it can be obtained via prescription or purchased directly from its maker, Veru. The FDA has also renamed the devices as “single-use internal condoms,” which must be biocompatible, maintain their performance characteristics throughout their shelf life, and bear adequate labeling.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report